In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Johnson & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback